NCT01165645 2022-12-01
Lopinavir and Ritonavir in Improving Immune Response to Vaccines in Patients With Complete Remission Following A Bone Marrow Transplant for Hodgkin Lymphoma
Mayo Clinic
Phase NA Withdrawn
Mayo Clinic
Mayo Clinic
University of California, San Diego
Wake Forest University Health Sciences
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
University of Southern California
Vanderbilt-Ingram Cancer Center